We are live on ! Find out more
DB

Dmitry Balyasny Balyasny Asset Management

AUM $80.2B
1-Year Est. Return 51.53%
 

Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.

This Fund
S&P 500
This Quarter Est. Return
-0.73%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.37%
10 Year Est. Return
+1,172.21%
AUM
$32.6B
AUM Growth
+$1.87B
Cap. Flow
+$3.25B
Cap. Flow %
9.96%
Top 10 Hldgs %
9.03%
Holding
3,497
New
825
Increased
816
Reduced
580
Closed
693

Top Sells

Rank Stock Value
1
BA icon
Boeing
BA
+$197M
2
TDG icon
TransDigm Group
TDG
+$181M
3
AAPL icon
Apple
AAPL
+$148M
4
ORCL icon
Oracle
ORCL
+$133M
5
ACC
American Campus Communities, Inc.
ACC
+$128M

Sector Composition

Rank Sector Weight
1 Industrials 11.6%
2 Technology 10.81%
3 Financials 10.76%
4 Consumer Discretionary 10.14%
5 Healthcare 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DVA icon
2901
PUT
DaVita
DVA
$11.1B
-78,000
Closed -$6.24M
DYN icon
2902
Dyne Therapeutics
DYN
$4.87B
-98,866
Closed -$679K
EAF icon
2903
GrafTech
EAF
$178M
-7,379
Closed -$522K
AXIA
2904
DELISTED
AXIA Energia
AXIA
-31,919
Closed -$224K
EE icon
2905
Excelerate Energy
EE
$1.23B
-177,213
Closed -$3.53M
EIDO icon
2906
iShares MSCI Indonesia ETF
EIDO
$495M
-25,612
Closed -$573K
EIX icon
2907
Edison International
EIX
$27.5B
-7,197
Closed -$455K
EL icon
2908
Estee Lauder
EL
$36.9B
-299,237
Closed -$76.2M
ELV icon
2909
Elevance Health
ELV
$86.9B
-47,588
Closed -$23M
ELV icon
2910
PUT
Elevance Health
ELV
$86.9B
-2,500
Closed -$1.21M
ENPH icon
2911
CALL
Enphase Energy
ENPH
$5.1B
-21,300
Closed -$4.16M
ENPH icon
2912
Enphase Energy
ENPH
$5.1B
-68,616
Closed -$18.5M
EOSE icon
2913
Eos Energy Enterprises
EOSE
$1.39B
-10,941
Closed -$13K
EPC icon
2914
Edgewell Personal Care
EPC
$1.32B
-183,000
Closed -$6.32M
ESE icon
2915
ESCO Technologies
ESE
$7.44B
-4,725
Closed -$323K
ESGR
2916
DELISTED
Enstar Group
ESGR
-13,660
Closed -$2.92M
ESTC icon
2917
Elastic
ESTC
$8.93B
-32,995
Closed -$2.23M
ETSY icon
2918
PUT
Etsy
ETSY
$7.44B
-48,000
Closed -$3.51M
EVGO icon
2919
EVgo
EVGO
$214M
-26,779
Closed -$161K
EVH icon
2920
CALL
Evolent Health
EVH
$536M
-100,000
Closed -$3.07M
EVRG icon
2921
Evergy
EVRG
$18.7B
-150,163
Closed -$9.8M
EW icon
2922
CALL
Edwards Lifesciences
EW
$51.8B
-182,000
Closed -$17.3M
EWBC icon
2923
East-West Bancorp
EWBC
$17.8B
-148,896
Closed -$9.65M
EWU icon
2924
CALL
iShares MSCI United Kingdom ETF
EWU
$3.98B
-200,000
Closed -$5.99M
EWU icon
2925
PUT
iShares MSCI United Kingdom ETF
EWU
$3.98B
-200,000
Closed -$5.99M

Similar funds

Dmitry Balyasny's Q3 2022 Portfolio in Review

As of Q3 2022, Dmitry Balyasny held 3,497 positions worth $32.6B, up 6.1% from $30.7B the previous quarter. Its ten largest holdings account for 9% of the portfolio.

Dmitry Balyasny deployed $3.25B of net new capital in Q3 2022, opening 825 new positions and adding to 816 existing holdings. Its largest new stake was Baxter International: 2,869,138 shares worth $155M.

By sector, the portfolio is most concentrated in Industrials at 12% of assets, down from 12% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Boeing, an estimated $197M trimmed.

  • Dmitry Balyasny's largest Q3 2022 buy was Baxter International: 2,869,138 shares worth $155M.
  • Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $213M increase.
  • Dmitry Balyasny's biggest Q3 2022 reduction was Boeing, cutting an estimated $197M.
  • Dmitry Balyasny fully exited TransDigm Group in Q3 2022, selling an estimated $181M.
  • Dmitry Balyasny's ten largest holdings make up 9% of its $32.6B portfolio in Q3 2022.
  • Dmitry Balyasny opened 825 new positions and closed 693 in Q3 2022.
  • Dmitry Balyasny's portfolio value rose 6.1% quarter-over-quarter to $32.6B.

Based on Balyasny Asset Management's 13F filing for Q3 2022, filed 15 Nov 2022.